Earnings Per Share (EPS) of $0.19 exceeded the estimated $0.13, showcasing a positive profitability trend.
Revenue reached approximately $73.1 million, with a year-over-year increase of 3.9%.
Significant financial growth with a 48% increase in net income and a 9% growth in adjusted EBITDA.
HealthStream, Inc. (NASDAQ:HSTM) is a leading healthcare technology company that focuses on providing workforce solutions. The company is known for its innovative platforms that help healthcare organizations improve their workforce’s skills and performance. HealthStream competes with other healthcare technology firms, striving to offer the best solutions in a rapidly evolving industry.
On October 21, 2024, HealthStream reported earnings per share (EPS) of $0.19, surpassing the estimated $0.13. This performance also exceeded the Zacks Consensus Estimate of $0.12 per share, as highlighted by Zacks. The EPS improvement from $0.13 in the same quarter last year indicates a positive trend in the company’s profitability.
HealthStream’s revenue for the third quarter was approximately $73.1 million, slightly below the estimated $74.3 million. However, this represents a 3.9% increase from the $70.3 million reported in the same quarter of 2023. The company’s operating income rose by 33.6% to $6.5 million, and net income increased by 48% to $5.7 million, showcasing strong financial growth.
The company’s adjusted EBITDA grew by 9% to $17.7 million, reflecting its ability to generate earnings before interest, taxes, depreciation, and amortization. HealthStream’s financial health is further supported by a low debt-to-equity ratio of 0.05, indicating a conservative approach to debt usage. The current ratio of 1.32 suggests that the company has sufficient liquidity to meet its short-term obligations.
HealthStream’s valuation metrics include a price-to-earnings (P/E) ratio of 43.85 and a price-to-sales ratio of 3.00. These figures indicate how much investors are willing to pay for each dollar of earnings and sales, respectively. The enterprise value to sales ratio of 2.87 and enterprise value to operating cash flow ratio of 13.69 provide additional insights into the company’s valuation relative to its revenue and cash flow.
